In carcinomas, the nature of CD40 ligand shapes the outcome of CD40 ligation. To date, the consequences of membrane-bound CD40L (mCD40L) on its immune-stimulatory function are unknown. Here, we examined the impact of mCD40L versus soluble CD40L (sCD40L) on T24 bladder carcinoma gene expression profiling. Of 410 differentially expressed genes, 286 were upregulated and 124 downregulated by mCD40L versus sCD40L. Gene ontology enrichment analysis revealed immunestimulatory function as the most significant enriched biological process affected by upregulated transcripts, while those downregulated were critical for cell growth and division. Furthermore, immature dendritic cells (iDC) responded to mCD40L with enhanced maturation and activation over sCD40L evidenced by higher expression levels of CD83, CD86, HLA-DR and CD54, increased secretion of IL12 and IL10 and higher tumour-antigen (TA) uptake capacity. Furthermore, autologus CD3+ T cells responded to TA-loaded mCD40L-activated DC with increased proliferation and cytotoxic response (CD107a and IFN-γ-producing CD3+ CD8+ T cells) to the tumour-loaded autologous PBMCs compared to sCD40L. Thus, these data indicate that mCD40L enhances the immunostimulatory capacity over sCD40L. Furthermore, the ability of mCD40L to also directly induce cell death in CD40-expressing carcinomas, subsequently releasing tumour-specific antigens into the tumour microenvironment highlights the potential for mCD40L as a multi-faceted anti-cancer immunotherapeutic. The fundamental role of the CD40 receptor, a member of the TNFR superfamily together with its ligand (CD40L/ CD154) in coordinating immune responses has been widely recognised as an early event in initiating immune responses 1. CD40, a 40-kD type 1 transmembrane protein is expressed in normal B cells, malignant hematopoietic cells and antigen presenting cells (APC), including dendritic cells (DC) and monocytes 2,3. Furthermore, activated CD4 + and CD8+ T cells also express CD40 receptor, where in absence of CD40 expression, CD8+ T cells were unable to differentiate into memory cells or receive CD4 help 4. In addition to hematopoietic cells, several carcinomas express CD40 receptor, including those of the ovary, liver, and bladder, despite receptor expression being undetectable in normal epithelium derived from the same tissue 5. In contrast to the wide-spectrum of CD40 expression, the expression of CD40L, a 32-kD protein is restricted mainly to activated CD4+ T cells and, to a lesser extent, activated B cells and platelets 6. In hematopoietic cells the importance of CD40-CD40L interaction is well-recognized particularly in shaping adaptive immune responses, where the outcome of CD40 ligation is cell-type dependant, with CD40 activation in DC leading to differentiation into IL12-and IFNγ-secreting cells and upregulation of co-stimulatory and adhesion molecules; while B cells respond by Ig-class switching 7. Furthermore, the strength of CD40 ligation by CD40L can influence the signalling outcome, with strong CD40 ligation enhancing anti...